Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriho Iida

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|April 14, 2019
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinomaNoriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, et al.
Biochemical Pharmacology|January 18, 2022
Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibitionAya Hasan Alshammari, Yusuke Masuo, Ken-Ichi Fujita, et al.
Cancer Research|July 29, 2010
Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alphaNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Cancer Letters|September 2, 2015
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinomaEishiro Mizukoshi, Hidetoshi Nakagawa, Masaaki Kitahara, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2016
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinomaEishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, et al.
Journal of Leukocyte Biology|July 23, 2008
Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in miceNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Therapeutic Advances in Gastroenterology|October 14, 2025
Utility of oral rehydration jelly in probe method endoscopic ultrasound: a prospective cohort studyShinya Yamada, Hajime Takatori, Masaki Miyazawa, et al.
Clinical Journal of Gastroenterology|September 12, 2025
Metachronous esophageal squamous cell carcinoma suspected as a second malignancy arising at the site of post-radiotherapy for esophageal adenocarcinomaHiroki Furusawa, Tomoyuki Hayashi, Koichi Okamoto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2018
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patientsMasashi Kumagai, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Arerugi = [Allergy]|August 21, 2003
[Hypereosinophilic syndrome with necrotizing vasculitis]Hirokazu Taniguchi, Shiho Fujisaka, Noriho Iida, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|April 14, 2019
Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinomaNoriho Iida, Eishiro Mizukoshi, Tatsuya Yamashita, et al.
Biochemical Pharmacology|January 18, 2022
Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibitionAya Hasan Alshammari, Yusuke Masuo, Ken-Ichi Fujita, et al.
Cancer Research|July 29, 2010
Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alphaNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Cancer Letters|September 2, 2015
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinomaEishiro Mizukoshi, Hidetoshi Nakagawa, Masaaki Kitahara, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2016
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinomaEishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, et al.
Journal of Leukocyte Biology|July 23, 2008
Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in miceNoriho Iida, Yasunari Nakamoto, Tomohisa Baba, et al.
Therapeutic Advances in Gastroenterology|October 14, 2025
Utility of oral rehydration jelly in probe method endoscopic ultrasound: a prospective cohort studyShinya Yamada, Hajime Takatori, Masaki Miyazawa, et al.
Clinical Journal of Gastroenterology|September 12, 2025
Metachronous esophageal squamous cell carcinoma suspected as a second malignancy arising at the site of post-radiotherapy for esophageal adenocarcinomaHiroki Furusawa, Tomoyuki Hayashi, Koichi Okamoto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2018
Immune response to human telomerase reverse transcriptase-derived helper T cell epitopes in hepatocellular carcinoma patientsMasashi Kumagai, Eishiro Mizukoshi, Toshikatsu Tamai, et al.
Arerugi = [Allergy]|August 21, 2003
[Hypereosinophilic syndrome with necrotizing vasculitis]Hirokazu Taniguchi, Shiho Fujisaka, Noriho Iida, et al.
Pageof 6